- Home
- WYY vs GDTC Comparison
WYY vs GDTC Comparison
Compare WYY & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYY
- GDTC
- Stock Information
- Founded
- WYY 1991
- GDTC 2018
- Country
- WYY United States
- GDTC Singapore
- Employees
- WYY N/A
- GDTC N/A
- Industry
- WYY EDP Services
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- WYY Technology
- GDTC Health Care
- Exchange
- WYY Nasdaq
- GDTC Nasdaq
- Market Cap
- WYY 33.6M
- GDTC 28.0M
- IPO Year
- WYY 1998
- GDTC 2023
- Fundamental
- Price
- WYY $3.15
- GDTC $2.02
- Analyst Decision
- WYY Strong Buy
- GDTC Buy
- Analyst Count
- WYY 1
- GDTC 1
- Target Price
- WYY $7.00
- GDTC $5.00
- AVG Volume (30 Days)
- WYY 62.3K
- GDTC 10.3K
- Earning Date
- WYY 08-13-2025
- GDTC 01-01-0001
- Dividend Yield
- WYY N/A
- GDTC N/A
- EPS Growth
- WYY N/A
- GDTC N/A
- EPS
- WYY N/A
- GDTC N/A
- Revenue
- WYY $142,582,209.00
- GDTC $368,838.00
- Revenue This Year
- WYY $10.84
- GDTC $5.37
- Revenue Next Year
- WYY $12.37
- GDTC N/A
- P/E Ratio
- WYY N/A
- GDTC N/A
- Revenue Growth
- WYY 24.03
- GDTC N/A
- 52 Week Low
- WYY $2.19
- GDTC $1.20
- 52 Week High
- WYY $6.25
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- WYY 40.96
- GDTC 41.07
- Support Level
- WYY $3.05
- GDTC $1.96
- Resistance Level
- WYY $3.38
- GDTC $2.26
- Average True Range (ATR)
- WYY 0.16
- GDTC 0.10
- MACD
- WYY 0.00
- GDTC -0.02
- Stochastic Oscillator
- WYY 2.44
- GDTC 17.95
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.